HIV Infections Clinical Trials

A listing of HIV Infections medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 353 clinical trials
Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW (LifeSkills)

demonstrate if the intervention will reduce HIV incidence.

Accepts healthy volunteers
  • 0 views
  • 04 Oct, 2022
  • 1 location
Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in Uganda

tuberculosis. Though the available literature is mostly from observational study designs, and is fraught with controversy, BCG vaccination at birth, in a high risk population of HIV exposed children, may

bcg vaccine
vaccination
antiretroviral
interleukin-6
Accepts healthy volunteers
  • 21 views
  • 07 Oct, 2022
  • 1 location
BAPS in Botswana: The Thotloetso Trial

The main purpose of this research study is to compare traditional behavioral smoking cessation therapy with a different type of behavioral therapy-known as behavioral activation problem solving (BAPS)-for smoking cessation. Standard smoking cessation counseling (SC) focuses on self-monitoring, identifying smoking triggers and how to manage them, relaxation and social support …

  • 0 views
  • 07 Oct, 2022
  • 1 location
Randomised, Double-Blind, Controlled Phase 3 Trial to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC Administered in Healthy HIV Unexposed and HIV Exposed Uninfected Newborns in Tuberculosis-Endemic Regions of Sub-Saharan Africa (MTBVACN3)

The objective of this project is to demonstrate safety, immunogenicity and improved efficacy of the new live attenuated M. tuberculosis vaccine called MTBVAC in a Phase 3 efficacy trial in HIV

Accepts healthy volunteers
  • 0 views
  • 23 Oct, 2022
  • 0 views
  • 20 Oct, 2022
  • 67 locations
Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected, Virologically Suppressed Pediatric Participants

Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) in HIV-1 infected, virologically suppressed adolescent participants weighing ≥ 25 kg (12 to < 18 years of age) To evaluate the safety

darunavir
antiretroviral agents
tuberculosis
HIV Vaccine
tenofovir
  • 298 views
  • 04 Oct, 2022
  • 9 locations
A Phase 3, Double-Blinded, Multicenter, Randomized Study to Evaluate Safety and Efficacy of Twice Yearly Long-Acting Subcutaneous Lenacapavir, and Daily Oral Emtricitabine/Tenofovir Alafenamide for Pre-Exposure Prophylaxis in Adolescent Girls and Young Women at Risk of HIV Infection (PURPOSE 1)

The primary objective of this study is to evaluate the efficacy of lenacapavir (LEN) and emtricitabine/tenofovir alafenamide (F/TAF) in preventing the risk of human immunodeficiency virus (HIV

Accepts healthy volunteers
  • 0 views
  • 23 Oct, 2022
  • 18 locations
Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)

this study, the investigators hope to learn if providing linkage to health services along with HIV, hepatitis C virus (HCV), and overdose education to people leaving rural jails or otherwise involved

HIV Vaccine
opioid
hepatitis
substance use
hepatitis c
  • 17 views
  • 04 Oct, 2022
  • 1 location
Thetha Nami Ngithethe Nawe ("Let's Talk"): Step Wedge cRCT of Peer Led Community PrEP and SRH for Youth in South Africa

Study Hypothesis: Social mobilisation will attract and engage young people into decentralised sexual reproductive health (SRH) services where HIV prevention is tailored to need. Decentralised

Accepts healthy volunteers
antiretroviral
  • 0 views
  • 04 Oct, 2022
  • 1 location
A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Adults Living With HIV

This study will evaluate the safety, tolerability, and immunogenicity of a pneumococcal 21-valent conjugate vaccine (V116) in persons living with human immunodeficiency virus (HIV), for the

polysaccharide
conjugate vaccine
  • 15 views
  • 23 Oct, 2022
  • 12 locations